133 related articles for article (PubMed ID: 25205713)
21. Matriptase-2 is essential for hepcidin repression during fetal life and postnatal development in mice to maintain iron homeostasis.
Willemetz A; Lenoir A; Deschemin JC; Lopez-Otin C; Ramsay AJ; Vaulont S; Nicolas G
Blood; 2014 Jul; 124(3):441-4. PubMed ID: 24904115
[TBL] [Abstract][Full Text] [Related]
22. Low intracellular iron increases the stability of matriptase-2.
Zhao N; Nizzi CP; Anderson SA; Wang J; Ueno A; Tsukamoto H; Eisenstein RS; Enns CA; Zhang AS
J Biol Chem; 2015 Feb; 290(7):4432-46. PubMed ID: 25550162
[TBL] [Abstract][Full Text] [Related]
23. A functional interplay between the two BMP-SMAD pathway inhibitors TMPRSS6 and FKBP12 regulates
Pettinato M; Aghajan M; Guo S; Bavuso Volpe L; Carleo R; Nai A; Pagani A; Altamura S; Silvestri L
Am J Physiol Gastrointest Liver Physiol; 2024 Mar; 326(3):G310-G317. PubMed ID: 38252872
[TBL] [Abstract][Full Text] [Related]
24. Role of matriptase-2 (TMPRSS6) in iron metabolism.
Lee P
Acta Haematol; 2009; 122(2-3):87-96. PubMed ID: 19907145
[TBL] [Abstract][Full Text] [Related]
25. Essential role of endocytosis of the type II transmembrane serine protease TMPRSS6 in regulating its functionality.
Béliveau F; Brulé C; Désilets A; Zimmerman B; Laporte SA; Lavoie CL; Leduc R
J Biol Chem; 2011 Aug; 286(33):29035-29043. PubMed ID: 21724843
[TBL] [Abstract][Full Text] [Related]
26. Liver HFE protein content is posttranscriptionally decreased in iron-deficient mice and rats.
Frýdlová J; Rogalsky DW; Truksa J; Traeger L; Steinbicker AU; Vokurka M; Krijt J
Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G560-G568. PubMed ID: 29927322
[TBL] [Abstract][Full Text] [Related]
27. TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals.
Nai A; Pagani A; Silvestri L; Campostrini N; Corbella M; Girelli D; Traglia M; Toniolo D; Camaschella C
Blood; 2011 Oct; 118(16):4459-62. PubMed ID: 21873547
[TBL] [Abstract][Full Text] [Related]
28. Iron absorption and metabolism.
Anderson GJ; Frazer DM; McLaren GD
Curr Opin Gastroenterol; 2009 Mar; 25(2):129-35. PubMed ID: 19528880
[TBL] [Abstract][Full Text] [Related]
29. Matriptase-2 (TMPRSS6) is directly up-regulated by hypoxia inducible factor-1: identification of a hypoxia-responsive element in the TMPRSS6 promoter region.
Maurer E; Gütschow M; Stirnberg M
Biol Chem; 2012 May; 393(6):535-40. PubMed ID: 22628316
[TBL] [Abstract][Full Text] [Related]
30. Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis.
Folgueras AR; de Lara FM; Pendás AM; Garabaya C; Rodríguez F; Astudillo A; Bernal T; Cabanillas R; López-Otín C; Velasco G
Blood; 2008 Sep; 112(6):2539-45. PubMed ID: 18523150
[TBL] [Abstract][Full Text] [Related]
31. Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms.
Ramsay AJ; Quesada V; Sanchez M; Garabaya C; Sardà MP; Baiget M; Remacha A; Velasco G; López-Otín C
Hum Mol Genet; 2009 Oct; 18(19):3673-83. PubMed ID: 19592582
[TBL] [Abstract][Full Text] [Related]
32. Discovery and Development of TMPRSS6 Inhibitors Modulating Hepcidin Levels in Human Hepatocytes.
Béliveau F; Tarkar A; Dion SP; Désilets A; Ghinet MG; Boudreault PL; St-Georges C; Marsault É; Paone D; Collins J; Macphee CH; Campobasso N; Groy A; Cottom J; Ouellette M; Pope AJ; Leduc R
Cell Chem Biol; 2019 Nov; 26(11):1559-1572.e9. PubMed ID: 31543462
[TBL] [Abstract][Full Text] [Related]
33. Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2.
Damalanka VC; Janetka JW
Future Med Chem; 2019 Apr; 11(7):743-769. PubMed ID: 30945556
[TBL] [Abstract][Full Text] [Related]
34. Effect of erythropoietin administration on proteins participating in iron homeostasis in Tmprss6-mutated mask mice.
Frýdlová J; Rychtarčíková Z; Gurieva I; Vokurka M; Truksa J; Krijt J
PLoS One; 2017; 12(10):e0186844. PubMed ID: 29073189
[TBL] [Abstract][Full Text] [Related]
35. 3-Amidinophenylalanine-derived matriptase inhibitors can modulate hepcidin production in vitro.
Pászti-Gere E; Szombath G; Gütschow M; Steinmetzer T; Székács A
Naunyn Schmiedebergs Arch Pharmacol; 2020 Mar; 393(3):511-520. PubMed ID: 31659405
[TBL] [Abstract][Full Text] [Related]
36. Activation of a membrane-bound serine protease matriptase on the cell surface.
Miyake Y; Yasumoto M; Tsuzuki S; Fushiki T; Inouye K
J Biochem; 2009 Aug; 146(2):273-82. PubMed ID: 19398443
[TBL] [Abstract][Full Text] [Related]
37. The optimal activity of a pseudozymogen form of recombinant matriptase under the mildly acidic pH and low ionic strength conditions.
Inouye K; Yasumoto M; Tsuzuki S; Mochida S; Fushiki T
J Biochem; 2010 Apr; 147(4):485-92. PubMed ID: 19919953
[TBL] [Abstract][Full Text] [Related]
38. Fine tuning of hepcidin expression by positive and negative regulators.
Muckenthaler MU
Cell Metab; 2008 Jul; 8(1):1-3. PubMed ID: 18590684
[TBL] [Abstract][Full Text] [Related]
39. The influence of matriptase-2 on prostate cancer in vitro: a possible role for β-catenin.
Webb SL; Sanders AJ; Mason MD; Jiang WG
Oncol Rep; 2012 Oct; 28(4):1491-7. PubMed ID: 22858929
[TBL] [Abstract][Full Text] [Related]
40. Haematologic data, iron parameters and molecular findings in two new cases of iron-refractory iron deficiency anaemia.
Tchou I; Diepold M; Pilotto PA; Swinkels D; Neerman-Arbez M; Beris P
Eur J Haematol; 2009 Dec; 83(6):595-602. PubMed ID: 19708871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
